Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Accessibility and harmonization of biochemical tests for diagnosis and monitoring of Porphyrias in the United States: Recommendations by members of the American Porphyrias Expert Collaborative (APEX).
Journal: Molecular genetics and metabolism
Published: February 17, 2026
Platelet response following dexamethasone in obese vs nonobese patients with primary, acute immune-mediated thrombocytopenia.
Journal: Research and practice in thrombosis and haemostasis
Published: January 27, 2025
Liver involvement in a large cohort of patients with erythropoietic protoporphyria or X-linked protoporphyria.
Journal: Hepatology communications
Published: August 29, 2024
Ahemolytic PNH (white cell PNH): Clinical features and implications of a distinct phenotype of paroxysmal nocturnal haemoglobinuria.
Journal: British journal of haematology
Published: November 20, 2023
Dersimelagon in Erythropoietic Protoporphyrias.
Journal: The New England journal of medicine
Published: April 12, 2023
Genome-wide uniparental disomy as a mechanism of immune escape in acquired aplastic anaemia.
Journal: British journal of haematology
Published: May 01, 2022
Anticoagulation management post-transjugular intrahepatic portosystemic shunt in portal hypertension associated with myeloproliferative neoplasms.
Journal: Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis
Published: October 05, 2021
Chronic graft-versus-host disease exacerbation after SARS-CoV-2 vaccination.
Journal: Bone marrow transplantation
Published: October 05, 2021
Efficacy and safety of givosiran for acute hepatic porphyria: 24-month interim analysis of the randomized phase 3 ENVISION study.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: August 31, 2021
ABCB6 polymorphisms are not overly represented in patients with porphyria.
Journal: Blood advances
Published: June 10, 2021
Phase 3 Trial of RNAi Therapeutic Givosiran for Acute Intermittent Porphyria.
Journal: The New England journal of medicine
Published: June 11, 2020
Last Updated: 09/26/2026